> ## Content Index
> Fetch the complete content index at: https://www.sanarelab.science/llms.txt
> Use this file to discover other available public pages before exploring further.

# DNA Nanorobot Carries Methylene Blue Deep Into Tumors: 85% Regression in Mice
- URL: https://www.sanarelab.science/methylene-blue-dna-nanorobot-hypoxic-tumor-2026/
- Published: 2026-09-27T08:11:06.000Z
- Updated: 2026-10-12T12:31:17.000Z
- Description: A self-propelled DNA nanorobot delivered methylene blue deep into oxygen-starved tumors, producing 85% tumor regression in mice via enhanced photodynamic therapy.
- Author: Sanare Lab
- Tags: #short-read, News, Research, Methylene Blue

Key Takeaway

Researchers have built a DNA "nanorobot" — a structure far smaller than a cell — that propels itself through oxygen-starved tumors and delivers methylene blue, a light-activated drug. In mice, it achieved 85% tumor regression (shrinkage). This is preclinical (animal-stage) research.

Solid tumors are hard to treat because they are hypoxic — starved of oxygen — and densely packed, so drugs barely penetrate them. The new nanorobot is built from DNA folded into a tetrahedron (a pyramid-shaped scaffold) carrying three tools: aptamers (short DNA strands that recognize tumor markers), platinum nanoparticles (tiny metal grains), and methylene blue as the payload.

The platinum grains break down hydrogen peroxide — a chemical tumors overproduce — and release oxygen. The oxygen bubbles work as a motor, driving the robot deeper than 300 micrometres (roughly the width of three human hairs) into tumor tissue, while the extra oxygen relieves hypoxia. That matters because methylene blue is a photosensitizer: when light shines on it, it generates molecules that kill cancer cells, a treatment called photodynamic therapy — and this works poorly without oxygen. The combined effect in mice was 85% tumor regression.

Context: this is a mouse-stage platform, years from any clinical use, and the methylene blue here is a light-activated drug delivered by a machine — not a supplement dose. For background, see [methylene blue in cancer research](https://www.sanarelab.science/methylene-blue-cancer-research-2026/) and the evidence map for [experimental cancer models](https://www.sanarelab.science/methylene-blue-in-experimental-cancer-models/); for dosing questions, our [dosing calculator](https://www.sanarelab.science/protocol-dosing-workspace/).

Product mentioned in our catalog: **Blue Essence Methylene Blue 10 mg liquid drops** — [view product →](https://sanarelab.com/products/blue-essence-methylene-blue-10-mg-liquid-drops-60-ml-2-fl-oz?ref=sanarelab.science). Links are informational; this is not an endorsement or medical advice.

## In plain words

**What happened:** Researchers built a tiny DNA-based carrier that delivers light-activated methylene blue and tested it in mice with oxygen-poor tumors.

**Why it matters:** The carrier was designed to make oxygen and move deeper into a tumor, helping the dye reach areas that are hard for medicines to reach.

**How strong is the evidence:** The reported tumor shrinkage was in mice. This is preclinical animal research, not evidence of safety or benefit in people.

**What it means for you:** Nothing changes in care today. This experimental carrier and light treatment have not been shown to help patients; do not use methylene blue for cancer on your own.

## References

1. Fan Q, Yao X, Sun B, et al. A Self-Propelled DNA-Based Nanorobot for Hypoxic Tumor Therapy. *Angew Chem Int Ed*. 2026 Sep 26\. [doi:10.1002/anie.7173496](https://doi.org/10.1002/anie.7173496?ref=sanarelab.science). [PMID: 42799652](https://pubmed.ncbi.nlm.nih.gov/42799652/?ref=sanarelab.science).

## Medical Disclaimer

This article is for informational purposes only and is not medical advice. The study was done in mice, not humans, and is not a clinical trial. Never start, stop or change any medication or supplement without consulting a licensed healthcare provider.